Hypertension: A Companion to Braunwald's Heart Disease: Companion to Braunwald's Heart Disease
Editat de George L. Bakris, Matthew Sorrentino, Luke J. Laffinen Limba Engleză Hardback – 4 ian 2024
Preț: 711.82 lei
Preț vechi: 933.85 lei
-24% Nou
Puncte Express: 1068
Preț estimativ în valută:
136.24€ • 140.40$ • 115.02£
136.24€ • 140.40$ • 115.02£
Carte disponibilă
Livrare economică 03-17 februarie
Livrare express 25-31 ianuarie pentru 256.24 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323883696
ISBN-10: 0323883699
Pagini: 640
Dimensiuni: 216 x 276 x 29 mm
Greutate: 1.58 kg
Ediția:4
Editura: Elsevier
Seria Companion to Braunwald's Heart Disease
ISBN-10: 0323883699
Pagini: 640
Dimensiuni: 216 x 276 x 29 mm
Greutate: 1.58 kg
Ediția:4
Editura: Elsevier
Seria Companion to Braunwald's Heart Disease
V-ar putea interesa
-
-27%Preț: 934.80 lei1278.10 lei -
Hypertensive Heart Disease, An Issue of Heart Failure ClinicsGeorge L. Bakris-21%Preț: 415.00 lei523.83 lei -
Prevention of Cardiovascular DiseaseEugene A. DeFelice-5%Preț: 99.88 lei105.14 lei -
"You're on the Air with Dr. Fratellone"Patrick Fratellone-5%Preț: 123.00 lei129.47 lei -
Glands in Health and Disease (1922)Benjamin Harrow-5%Preț: 113.35 lei119.31 lei -
Notes from the Editor's Corner of Cath Lab DigestMorton J. Kern MD-5%Preț: 264.67 lei278.61 lei -
I Can See Your HeartbeatJeff Schoeben-5%Preț: 103.28 lei108.72 lei -
Managing the Kidney when the Heart is FailingGeorge L. Bakris-5%Preț: 360.14 lei379.09 lei -
The Kidney in Heart FailureGeorge L. Bakris-5%Preț: 776.98 lei817.88 lei -
Heart Attack... or IndigestionRoberto P. Medina MD-5%Preț: 45.42 lei47.82 lei -
A Public Health Action Plan to Prevent Heart Disease and StrokeStaff at Congressional Research Service-5%Preț: 181.45 lei191.00 lei -
Open Heart Bypass Surgery to Fix DefectsDr/ Jon Schiller Phd-5%Preț: 286.01 lei301.07 lei -
Heart Disease and Chest RadiographyMisty L. Wesley-5%Preț: 58.82 lei61.92 lei -
Lower Extremity Arterial DiseaseDennis G. Caralis-5%Preț: 725.42 lei763.60 lei -
Diabetes and Hypertension: Evaluation and ManagementSamy I. McFarlane-5%Preț: 1340.92 lei1411.49 lei -
Dilated Cardiomyopathy: From Genetics to Clinical ManagementGianfranco Sinagra-5%Preț: 337.30 lei355.06 lei -
-5%Preț: 569.75 lei599.74 lei -
-5%Preț: 730.28 lei768.71 lei -
Cardiac Electrophysiology Without FluoroscopyRiccardo Proietti-5%Preț: 712.20 lei749.69 lei -
Noncompaction CardiomyopathyKadir Caliskan-5%Preț: 391.69 lei412.30 lei -
-5%Preț: 390.36 lei410.91 lei -
Cardiovascular Hemodynamics: An Introductory GuideArman T. Askari-5%Preț: 607.28 lei639.24 lei -
-5%Preț: 551.27 lei580.28 lei -
Cardiac Repolarization: Basic Science and Clinical ManagementNabil El-Sherif-5%Preț: 572.41 lei602.53 lei -
Managing Diabetic Nephropathies in Clinical PracticeGeorge L. Bakris-5%Preț: 360.14 lei379.09 lei -
-5%Preț: 375.54 lei395.30 lei
Cuprins
SECTION I: EPIDEMIOLOGY AND PREVENTIVE STRATEGIES
1. General Population and Global Cardiovascular Risk Prediction
2. Diet and Hypertension
3. Exercise and Hypertension
4. Hypertension in Women
SECTION II: PATHOPHYSIOLOGY
5. Pathophysiology of Hypertension
6. Genetics of Hypertension
7. Inflammation and Immunity in Hypertension
SECTION III: DIAGNOSIS AND EVALUATION
8. The Environment and High Blood Pressure
9. Office Blood Pressure Measurement
10. Home Monitoring of Blood Pressure
11. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management
12. White Coat and Masked Hypertension
13. Renovascular Hypertension and ISchemic Neuropathy
14. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States
15. Secondary Hypertension: Pheochromocytoma and Paraganglioma
16. Sleep Disruption and Blood Pressure
SECTION IV: RISK STRATIFICATION
17. The Natural History of Untreated Hypertension
18. Isolated Systolic Hypertension
19. Assessment of Hypertension-Mediated Organ Damage
SECTION V: ANTIHYPERTENSIVE THERAPY
20. Diuretics Therapy
21. Calcium Channel Blockers
22. Renin Angiotensin Aldosterone System Blockers
23. Aldosterone and Hypertension
24. ß-Blockers, Central Sympathetic Agents,and Direct Vasodilators
25. Peripheral Alpha Blockers
26. Initial Combination Therapies
27. Devices Therapies for Hypertension
28. The Treatment of Hypertension With Nutrition, Nutritional Supplements, and Lifestyle
SECTION VI: HYPERTENSION MANAGEMENT APPROACHES
29. Approach to Difficult to Manage Primary Hypertension
30. Team-Based Care for Hypertension Management
31. Medication Adherence: Focus on Improvement
32. Digital Health and Telemedicine for Hypertension
SECTION VII HYPERTENSION MANAGEMENT WITH COMORBIDITIES
33. Ischemic Heart Disease
34. Heart Failure
35. Hypertension and Chronic Kidney Disease Including Dialysis
36. Transplant Hypertension
37. Obesity and Hypertension: Pathophysiology and Treatment
38. Cerebrovascular Disease
39. Diabetes Mellitus: Management of Hypertension in Diabetes
40. Onco-Hypertension: Anticancer Therapy-Associated Hypertension
41. Autonomic Dysfunction and Orthostatic Hypotension
42. Dyslipidemia
43. Aorta and Peripheral Arterial Disease in Hypertension
SECTION VIII SPECIAL POPULATIONS
44. Hypertension in Pregnancy
45. Hypertension in Older People
46. Hypertension in African Americans
47. Resistant Hypertension
48. Hypertensive Emergencies and Urgencies
49. Hypertension in Children: Diagnosis and Treatment
Appendix Meta-Analyses of Blood Pressure Lowering Trials
Index
1. General Population and Global Cardiovascular Risk Prediction
2. Diet and Hypertension
3. Exercise and Hypertension
4. Hypertension in Women
SECTION II: PATHOPHYSIOLOGY
5. Pathophysiology of Hypertension
6. Genetics of Hypertension
7. Inflammation and Immunity in Hypertension
SECTION III: DIAGNOSIS AND EVALUATION
8. The Environment and High Blood Pressure
9. Office Blood Pressure Measurement
10. Home Monitoring of Blood Pressure
11. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management
12. White Coat and Masked Hypertension
13. Renovascular Hypertension and ISchemic Neuropathy
14. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States
15. Secondary Hypertension: Pheochromocytoma and Paraganglioma
16. Sleep Disruption and Blood Pressure
SECTION IV: RISK STRATIFICATION
17. The Natural History of Untreated Hypertension
18. Isolated Systolic Hypertension
19. Assessment of Hypertension-Mediated Organ Damage
SECTION V: ANTIHYPERTENSIVE THERAPY
20. Diuretics Therapy
21. Calcium Channel Blockers
22. Renin Angiotensin Aldosterone System Blockers
23. Aldosterone and Hypertension
24. ß-Blockers, Central Sympathetic Agents,and Direct Vasodilators
25. Peripheral Alpha Blockers
26. Initial Combination Therapies
27. Devices Therapies for Hypertension
28. The Treatment of Hypertension With Nutrition, Nutritional Supplements, and Lifestyle
SECTION VI: HYPERTENSION MANAGEMENT APPROACHES
29. Approach to Difficult to Manage Primary Hypertension
30. Team-Based Care for Hypertension Management
31. Medication Adherence: Focus on Improvement
32. Digital Health and Telemedicine for Hypertension
SECTION VII HYPERTENSION MANAGEMENT WITH COMORBIDITIES
33. Ischemic Heart Disease
34. Heart Failure
35. Hypertension and Chronic Kidney Disease Including Dialysis
36. Transplant Hypertension
37. Obesity and Hypertension: Pathophysiology and Treatment
38. Cerebrovascular Disease
39. Diabetes Mellitus: Management of Hypertension in Diabetes
40. Onco-Hypertension: Anticancer Therapy-Associated Hypertension
41. Autonomic Dysfunction and Orthostatic Hypotension
42. Dyslipidemia
43. Aorta and Peripheral Arterial Disease in Hypertension
SECTION VIII SPECIAL POPULATIONS
44. Hypertension in Pregnancy
45. Hypertension in Older People
46. Hypertension in African Americans
47. Resistant Hypertension
48. Hypertensive Emergencies and Urgencies
49. Hypertension in Children: Diagnosis and Treatment
Appendix Meta-Analyses of Blood Pressure Lowering Trials
Index